Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center

American Journal of Preventive Cardiology · Published 2026-07-01 · DOI 10.1016/j.ajpc.2026.101733

Free full text

Authors (7)

Eleonora Avenatti, Archana Sadhu, Rakesh Gullapelli, Aditi Rao, Chetan Pavuluri, Khurram Nasir, Sangeeta R. Kashyap

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Avenatti, E., Sadhu, A., Gullapelli, R., et al. (2026). Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center. American Journal of Preventive Cardiology. https://doi.org/10.1016/j.ajpc.2026.101733

Related articles